Characteristics | Total number (N = 123) | CEA mRNA | P value | |
---|---|---|---|---|
Positive (n = 45) | Negative (n = 78) | |||
Age | Â | Â | Â | Â |
   ≤40 | 13 | 3 | 10 |  |
   41-50 | 20 | 9 | 11 |  |
   51-60 | 39 | 9 | 30 |  |
   61-70 | 42 | 18 | 24 |  |
   >70 | 9 | 6 | 3 | 0.063 |
Sex | Â | Â | Â | Â |
   Female | 41 | 12 | 29 |  |
   Male | 82 | 33 | 49 | 0.234 |
Tumor | Â | Â | Â | Â |
   T1 | 10 | 6 | 4 |  |
   T2 | 16 | 3 | 13 |  |
   T3 | 73 | 26 | 47 |  |
   T4 | 24 | 10 | 14 | 0.001 |
Lymph node | Â | Â | Â | Â |
   N0 | 31 | 11 | 20 |  |
   N1 | 43 | 15 | 28 |  |
   N2 | 29 | 8 | 21 |  |
   N3 | 20 | 11 | 9 | 0.261 |
Pathologic TNM# stage | Â | Â | Â | Â |
   I | 16 | 7 | 9 |  |
   II | 21 | 6 | 15 |  |
   III | 51 | 17 | 34 |  |
   IV | 35 | 15 | 20 | 0.623 |
Histology subtype | Â | Â | Â | Â |
   Well differentiated adenocarcinoma | 3 | 1 | 2 |  |
   Moderately differentiated adenocarcinoma | 27 | 7 | 20 |  |
   Poorly differentiated adenocarcinoma | 93 | 37 | 56 | 0.418 |
Serum CEA condition | Â | Â | Â | Â |
   Positive | 30 | 11 | 19 |  |
   Negative | 93 | 34 | 59 | 0.992 |
Recurrence | Â | Â | Â | Â |
   Yes | 44 | 25 | 19 |  |
   No | 79 | 20 | 59 | 0.001 |
Modes of recurrence | Â | Â | Â | Â |
Local recurrence | 8 | 4 | 4 | Â |
   Abdominal cavity | 9 | 6 | 3 |  |
   Liver | 8 | 5 | 3 |  |
   pelvic | 6 | 3 | 3 |  |
   Multiple sites | 10 | 5 | 5 |  |
   others | 3 | 2 | 1 | 0.959 |